Cathie Wood makes it easy to keep tabs on her aggressive growth stock habits. The co-founder, CEO, and investment manager of the Ark Invest family of exchange-traded funds publishes her transactions at the end of every trading day. She became a widely followed player with monster returns in 2020. She followed back-to-back years of disappointing returns with another market-thumping performance last year.

Things haven't gone so well in 2024, but it's not stopping her from fine-tuning her collection of growth stocks day by day. Wood added to her existing positions in (NYSE: SHOP), Intellia Therapeutics (NASDAQ: NTLA), and Adaptive Biotechnologies (NASDAQ: ADPT) on Tuesday. Let's take a closer look at the stocks that are trading 16% to 29% lower in 2024.

The online retailing giant is one of Wood's 10 largest holdings across her combined portfolios, playing a small part in her market-trouncing performance last year as well as this year's slide. Shares of the e-commerce platform that gives sellers of all sizes a way to get their digital storefronts noticed more than doubled last year. The stock is down 27% in 2024, and a poorly received financial update earlier this month didn't help.

Continue reading

Source Fool.com